Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Fluoxetine versus trazodone: efficacy and activating-sedating effects.

Beasley CM Jr, Dornseif BE, Pultz JA, Bosomworth JC, Sayler ME.

J Clin Psychiatry. 1991 Jul;52(7):294-9.

PMID:
2071559
2.
3.

Fluoxetine versus trazodone in the treatment of outpatients with major depression.

Debus JR, Rush AJ, Himmel C, Tyler D, Polatin P, Weissenburger J.

J Clin Psychiatry. 1988 Nov;49(11):422-6.

PMID:
3053668
4.

Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.

J Clin Psychiatry. 1991 Aug;52(8):329-35.

PMID:
1907963
5.

Fluoxetine: activating and sedating effects at multiple fixed doses.

Beasley CM Jr, Sayler ME, Weiss AM, Potvin JH.

J Clin Psychopharmacol. 1992 Oct;12(5):328-33.

PMID:
1479050
6.

Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.

Tollefson GD, Holman SL, Sayler ME, Potvin JH.

J Clin Psychiatry. 1994 Feb;55(2):50-9.

PMID:
8077155
7.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
8.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
9.

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.

Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.

Biol Psychiatry. 2006 Jun 1;59(11):1052-60. Epub 2006 Apr 3.

PMID:
16581036
10.

High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.

Beasley CM Jr, Sayler ME, Bosomworth JC, Wernicke JF.

J Clin Psychopharmacol. 1991 Jun;11(3):166-74.

PMID:
2066455
11.

A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.

Bennie EH, Mullin JM, Martindale JJ.

J Clin Psychiatry. 1995 Jun;56(6):229-37.

PMID:
7775364
12.

Efficacy and safety of morning versus evening fluoxetine administration.

Usher RW, Beasley CM Jr, Bosomworth JC.

J Clin Psychiatry. 1991 Mar;52(3):134-6.

PMID:
2005078
13.

Zolpidem for persistent insomnia in SSRI-treated depressed patients.

Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK.

J Clin Psychiatry. 1999 Oct;60(10):668-76.

PMID:
10549683
14.

Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial.

Beasley CM Jr, Sayler ME, Potvin JH.

Int Clin Psychopharmacol. 1993 Fall;8(3):143-9.

PMID:
8263311
15.

Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.

Feiger AD, Heiser JF, Shrivastava RK, Weiss KJ, Smith WT, Sitsen JM, Gibertini M.

J Clin Psychiatry. 2003 Mar;64(3):243-9.

PMID:
12716264
16.
17.

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

Fava M, Hoog SL, Judge RA, Kopp JB, Nilsson ME, Gonzales JS.

J Clin Psychopharmacol. 2002 Apr;22(2):137-47.

PMID:
11910258
18.

Citalopram treatment of fluoxetine-intolerant depressed patients.

Calabrese JR, Londborg PD, Shelton MD, Thase ME.

J Clin Psychiatry. 2003 May;64(5):562-7.

PMID:
12755660
20.

Supplemental Content

Support Center